168 related articles for article (PubMed ID: 14567021)
41. Gastrectomy, peritonectomy, and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer.
Sugarbaker PH; Yu W; Yonemura Y
Semin Surg Oncol; 2003; 21(4):233-48. PubMed ID: 14648781
[TBL] [Abstract][Full Text] [Related]
42. The treatment of advanced gastric cancer: new findings on the activity of the taxanes.
Van Cutsem E
Oncologist; 2004; 9 Suppl 2():9-15. PubMed ID: 15161986
[TBL] [Abstract][Full Text] [Related]
43. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials.
Mi DH; Li Z; Yang KH; Cao N; Lethaby A; Tian JH; Santesso N; Ma B; Chen YL; Liu YL
Int J Hyperthermia; 2013; 29(2):156-67. PubMed ID: 23418917
[TBL] [Abstract][Full Text] [Related]
44. Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program.
Leichman L; Silberman H; Leichman CG; Spears CP; Ray M; Muggia FM; Kiyabu M; Radin R; Laine L; Stain S
J Clin Oncol; 1992 Dec; 10(12):1933-42. PubMed ID: 1453207
[TBL] [Abstract][Full Text] [Related]
45. [Study on adjuvant MTX-5-FU intraperitoneal chemotherapy for advanced gastric cancer].
Maruyama M; Nagahama T; Sato E; Maruyama S; Sanada T; Koide A; Ohhinata R; Ebana H
Gan To Kagaku Ryoho; 2008 Nov; 35(12):1993-5. PubMed ID: 19106501
[TBL] [Abstract][Full Text] [Related]
46. Pre-adjuvant chemotherapy leukocyte count may predict the outcome for advanced gastric cancer after radical resection.
Pei D; Zhu F; Chen X; Qian J; He S; Qian Y; Shen H; Liu Y; Xu J; Shu Y
Biomed Pharmacother; 2014 Mar; 68(2):213-7. PubMed ID: 24581723
[TBL] [Abstract][Full Text] [Related]
47. Postoperative chemotherapy for patients with advanced gastric cancer.
Maehara Y; Emi Y; Moriguchi S; Takahashi I; Yoshida M; Kusumoto H; Sugimachi K
Am J Surg; 1992 Jun; 163(6):577-80. PubMed ID: 1595836
[TBL] [Abstract][Full Text] [Related]
48. The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.
Desiderio J; Chao J; Melstrom L; Warner S; Tozzi F; Fong Y; Parisi A; Woo Y
Eur J Cancer; 2017 Jul; 79():1-14. PubMed ID: 28456089
[TBL] [Abstract][Full Text] [Related]
49. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
[TBL] [Abstract][Full Text] [Related]
50. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
Fujiwara Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Okada K; Mori M; Doki Y
Ann Surg Oncol; 2011 Dec; 18(13):3726-31. PubMed ID: 21584835
[TBL] [Abstract][Full Text] [Related]
51. Clinical Efficacy of Combination Intravenous and Intraperitoneal Chemotherapy in the Treatment of Gastric Cancer with Peritoneal Carcinomatosis.
Zhang S; Feng R; Pan Z; Lin M; Huang X; Jiang T; Xu Q; Chen Q; Yang S
Curr Pharm Biotechnol; 2018; 19(12):956-962. PubMed ID: 30426896
[TBL] [Abstract][Full Text] [Related]
52. Postoperative adjuvant chemotherapy is effective in gastric cancer with serosal invasion: significance in patients chosen for multivariate analysis.
Takiguchi N; Fujimoto S; Koda K; Oda K; Okui K; Nakajima N; Miyazaki M
Oncol Rep; 2002; 9(4):801-6. PubMed ID: 12066212
[TBL] [Abstract][Full Text] [Related]
53. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center.
Wu HT; Peng KW; Ji ZH; Sun JH; Zhang Q; Yang XJ; Huang CQ; Li Y
Eur J Surg Oncol; 2016 Jul; 42(7):1024-34. PubMed ID: 27179924
[TBL] [Abstract][Full Text] [Related]
54. Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?
Briasoulis E; Fatouros M; Roukos DH
Ann Surg Oncol; 2007 Oct; 14(10):2691-5. PubMed ID: 17653806
[No Abstract] [Full Text] [Related]
55. [Stomach carcinoma. Optimizing therapy by neoadjuvant or adjuvant therapy?].
Rosen H
Zentralbl Chir; 1999; 124(5):387-93. PubMed ID: 10420523
[TBL] [Abstract][Full Text] [Related]
56. Curative Gastrectomy with Perioperative Chemotherapy Improves the Survival for Unresectable Gastric Cancer.
Otowa Y; Suzuki S; Kanaji S; Harada H; Tanaka T; Yamamoto M; Matsuda Y; Oshikiri T; Nakamura T; Kakeji Y
Anticancer Res; 2018 Apr; 38(4):2363-2368. PubMed ID: 29599362
[TBL] [Abstract][Full Text] [Related]
57. Intraarterial chemotherapy as an adjuvant treatment in locally advanced gastric cancer.
Tentes AA; Markakidis SK; Karanikiotis C; Fiska A; Tentes IK; Manolopoulos VG; Dimitriou T
Langenbecks Arch Surg; 2006 Apr; 391(2):124-9. PubMed ID: 16534653
[TBL] [Abstract][Full Text] [Related]
58. A phase II trial of perioperative chemotherapy involving a single intraperitoneal administration of paclitaxel followed by sequential S-1 plus intravenous paclitaxel for serosa-positive gastric cancer.
Peng YF; Imano M; Itoh T; Satoh T; Chiba Y; Imamoto H; Tsubaki M; Nishida S; Yasuda T; Furukawa H
J Surg Oncol; 2015 Jun; 111(8):1041-6. PubMed ID: 26060133
[TBL] [Abstract][Full Text] [Related]
59. Surgical treatment for peritoneal carcinomatosis from gastric cancer.
Yonemura Y; Endou Y; Sasaki T; Hirano M; Mizumoto A; Matsuda T; Takao N; Ichinose M; Miura M; Li Y
Eur J Surg Oncol; 2010 Dec; 36(12):1131-8. PubMed ID: 20933363
[TBL] [Abstract][Full Text] [Related]
60. Inflammatory lesions of the peritoneum mimic carcinomatosis after treatment with intravenous chemotherapy and intraperitoneal catumaxomab.
Rüssel J; Stein A; Behrmann C; Hauptmann S; Krummenerl P; Schmoll HJ; Arnold D
J Clin Oncol; 2011 Aug; 29(22):e644-6. PubMed ID: 21606410
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
